BOPI 07 BR/2024 REPERTOIRE NUMERIQUE 22 ________________________________________ (11) 21588 Consulter le mémoire (51) A61K 39/04 (2018.01); A61P 13/10 (2018.01) ; A61P 35/00 (2018.01) (21) 1202400025 - PCT/EP2022/070373 (22) 20/07/2022 (30) EP n° 21187253.6 du 22/07/2021; US n° 63/224,575 du 22/07/2021 et US n° 17/667,784 du 09/02/2022 (54) Recombinant mycobacterium as an immunotherapeutic agent for the second-line therapy of bladder carcinoma. (72) GRODE, Leander (DE) (73) 1- SERUM LIFE SCIENCE EUROPE GMBH, Ahrensburger Strasse 1, 30659 HANNOVER (DE) et 2- SERUM INSTITUTE OF INDIA LTD., 212/2, Off Soli Poonawalla Road, Hadapsar Maharashtra, PUNE 411 028 (IN) (74) S.C.P. AKKUM AKKUM & Associates, No. 1777, Rue 6.261, Auditorium Jean Paul II, Quartier Mbankolo, B.P. 4966, YAOUNDE (CM). (57) The invention relates to a recombinant Mycobacterium cell for use as an immunotherapeutic agent in the treatment of bladder carcinoma, particularly in the second-5 line treatment of non-muscle-invasive bladder carcinoma. Fig. 1 ________________________________________ (11) 21589 Consulter le mémoire (51) C04B 20/02 (2018.01) (21) 1202400035 - PCT/FR2022/051534 (22) 01/08/2022 (30) FR n° FR21/08401 du 02/08/2021 (54) Procédé de carbonatation accélérée et sa mise en œuvre dans un procédé de valorisation de déchets de béton et de rejets gazeux industriels.
RkJQdWJsaXNoZXIy MTM1NDc3MA==